Selling to Private Equity vs. an Individual Buyer: Which Is Right for Your Practice?
- Right Fit Capital
- Mar 16
- 7 min read
Updated: Mar 21
If you're considering selling your veterinary or optometry practice, you'll face a decision that most owners aren't prepared for: who do you actually sell to?
On one side: private equity-backed consolidators with deep pockets, professional deal teams, and a fast-moving acquisition process. On the other: individual buyers — associate DVMs, ODs, or local operators — who typically offer a simpler, more personal transaction at a lower headline price.
The right answer isn't universal. It depends on your financial goals, your timeline, how much you care about what happens to your practice after you leave, and whether you want a clean exit or are willing to stay on for a few years in exchange for a bigger check.
This article breaks down both buyer types — the real tradeoffs, not just the sales pitch — so you can make the decision that's right for you.
The Two Main Buyer Types, Briefly
Selling Practice To Private Equity
PE-backed platforms acquire independent practices to build scale — regional or national networks they can eventually sell or take public. In veterinary medicine, platforms like Southern Veterinary Partners, Mission Veterinary Partners, and Rarebreed have been aggressively buying practices for years. In optometry, groups like Eyecare Partners, MyEyeDr., and dozens of smaller regional platforms are doing the same.
These buyers move with professional deal teams — M&A attorneys, accountants, and integration specialists. They know exactly what they want, they pay the highest multiples in the market, and they have a standardized process for getting deals done.
Individual Buyers
Individual buyers are associate veterinarians, optometrists, or small independent operators looking to own their first practice. They typically finance through SBA 7(a) loans, which caps deal size (generally up to $5M) and introduces bank underwriting into the process. Deals are simpler, timelines can be shorter, and the post-close experience tends to be more relationship-based.
The Honest Comparison
1. Purchase Price
PE-backed consolidators pay more. Full stop. For a well-run veterinary practice, a PE buyer might offer 6x–10x EBITDA. An individual DVM buyer, constrained by SBA financing, is more likely in the 4x–5x range. The same general pattern holds in optometry.
On a practice generating $300,000 in EBITDA, that's the difference between a $1.2M–$1.5M offer from an individual buyer and a $1.8M–$3M offer from a PE consolidator. That gap is real and material.
But here's the catch: PE buyers often structure a portion of consideration as an earnout or equity rollover rather than cash at close. If your earnout is tied to post-close performance metrics that the new management controls, it may not pay out the way the headline number suggests. Understand exactly what's cash at close before comparing offers.
2. Deal Complexity and Timeline
Individual buyers are simpler and faster — but not always. SBA financing introduces the bank as a third party, which can slow or derail deals if underwriting hits a snag. A typical individual buyer transaction takes 3–5 months from LOI to close.
PE transactions are more complex — 6–12 months is standard, sometimes longer. They involve larger due diligence processes, more attorneys, more documentation, and more integration planning. That's not necessarily a problem, but it is a commitment. You'll spend significant time working through the process while still running your practice.
3. What Happens to Your Practice After Close
This is the question most sellers don't ask until it's too late.
With a PE consolidator: Your practice becomes part of a larger system. That means standardized protocols, centralized HR, shared services, pricing adjustments, and in many cases, changes to how the practice operates day to day. When selling practice to private equity, some consolidators are excellent operators who run their acquired practices well. Others slash associate pay, push volume, and reduce the quality of care. The reputation varies significantly by platform — due diligence on the buyer matters as much as their due diligence on you.
With an individual buyer: The practice typically continues much as it was. A motivated individual buyer — usually someone who has been working in the profession for years and genuinely wants to build something — tends to be more invested in continuity. Patients usually don't notice the transition. Staff often stays. The culture persists.
If the legacy of the practice matters to you — the staff you've built, the patient relationships, the way care is delivered — this difference is significant.
4. Your Role After the Sale
PE buyers almost always require a transition period. In veterinary medicine, this is typically 1–3 years of continued employment post-close. In optometry, often 1–2 years. During this period you're an employee, not an owner. There's a non-compete, a defined compensation package, and expectations around production and availability. For some sellers, this is fine — they want the income and the gradual wind-down. For others, the loss of control and the employment structure is a difficult adjustment.
Individual buyers are more flexible on transition terms. A 3–6 month transition is common. Some deals involve no ongoing employment at all — the buyer is ready to operate independently and doesn't need the seller to stay. If you want a clean exit quickly, an individual buyer is more likely to accommodate that.
5. Equity Rollover: The PE-Specific Option
Many PE-backed consolidators offer equity rollover — the option to take a portion of your sale proceeds in the form of equity in the larger platform rather than cash. The pitch: when the platform eventually exits (via sale to a larger PE firm or strategic buyer), your rollover equity could be worth significantly more than what you received at close.
This has worked out extremely well for some sellers. It has also produced nothing for others — particularly when platforms underperformed, restructured, or held the asset longer than expected without a clean exit.
Equity rollover is a bet on the platform's future performance. If you take it, do your homework on the platform's track record, their existing portfolio size, and their expected exit timeline. If you don't have high conviction, take the cash.
6. Deal Certainty
PE buyers have more capital and fewer financing contingencies — which generally means higher deal certainty once an LOI is signed. Individual buyers, relying on SBA financing, are more exposed to the risk of the bank pulling back or requesting additional conditions mid-process.
That said, PE deals can also fall apart — usually in due diligence, when something surfaces that the buyer didn't expect. The solution on either side: be prepared, be transparent, and have your documentation in order before the process starts. For a breakdown of what gets practices into trouble at this stage, see the top mistakes business owners make when approached by buyers.
Decision Framework: Which Buyer Is Right for You?
Consider a PE-backed consolidator if:
Maximizing total proceeds is your primary goal
Your practice has $500K+ in EBITDA and strong financials
You're willing to stay on as an employed DVM or OD for 1–3 years post-close
You're open to the practice changing operationally after the sale
You have the time and energy for a 6–12 month transaction process
You're interested in equity rollover as a potential upside play
Consider an individual buyer if:
A clean, fast exit matters more than squeezing every dollar out of the price
Practice continuity — for staff, patients, and culture — is a priority
You want a shorter or no transition period
Your practice is smaller (under $500K EBITDA) and may not meet PE acquisition criteria
You want to sell to someone with genuine stakes in the practice's long-term quality of care
The best situations involve having both options in play at the same time. When you're fielding interest from a PE consolidator and a qualified individual buyer simultaneously, you have negotiating leverage you simply don't have when you're talking to one party in isolation.
This is exactly what Right Fit Capital is designed for — making curated introductions to multiple buyer types so that sellers can evaluate real offers side by side rather than accepting the first term sheet that arrives. Understanding your options is the foundation of any well-executed exit.
What About the Hybrid: Selling to a Regional or Strategic Buyer?
Worth noting: the market isn't binary. Between large PE-backed platforms and individual buyers sits a middle category — regional multi-practice groups, local DSOs and VSOs (dental/veterinary service organizations), and strategic acquirers building a footprint in a specific market.
These buyers sometimes offer the best of both worlds: higher multiples than individual buyers, but more flexibility on transition terms, culture fit, and post-close autonomy than a large PE roll-up. They're often less well-known, but for the right practice in the right market, they can be the best fit of all.
The challenge: finding them. They don't advertise broadly, and they're rarely the ones bidding on the practices listed on public broker marketplaces. Relationships and network-based introductions are how these deals get done — which is precisely the kind of matchmaking work Right Fit Capital does.
The Bottom Line
There is no universally correct answer to "PE or individual buyer?" The question is which trade-offs you're willing to make.
PE consolidators offer the highest prices but the most post-close change. Individual buyers offer continuity and simplicity but typically at lower multiples. Regional and strategic buyers can split the difference if you can find them.
The sellers who get the best outcomes aren't the ones who pick the right buyer type in the abstract — they're the ones who run a thoughtful process, understand their options, and negotiate from a position of knowledge rather than desperation or naivety.
That starts with knowing what your practice is worth — see what your veterinary practice is really worth or what optometry practice buyers want in 2025 — and it ends with the right introduction to the right buyer.
Right Fit Capital works with independent practice owners in veterinary and optometry M&A to make exactly that introduction — curated, direct, and tied to results. No listing fee. No commission on work that doesn't close. Just the right buyer for your practice.
Right Fit Capital specializes in deal origination for independent healthcare practice owners in veterinary and optometry M&A. We connect sellers with the right buyers — consolidators, PE-backed platforms, and regional acquirers.
